Header Logo

Connection

Jennifer McClure to Middle Aged

Back to Details
This is a "connection" page, showing publications Jennifer McClure has written about Middle Aged.
Jennifer McClure
Connection Strength
1.301
Middle Aged
  1. Exploring the "active ingredients" of an online smoking intervention: a randomized factorial trial. Nicotine Tob Res. 2014 Aug; 16(8):1129-39.
    View in: PubMed
    Score: 0.049
  2. [More] evidence to support oral health promotion services targeted to smokers calling tobacco quitlines in the United States. BMC Public Health. 2013 Apr 11; 13:336.
    View in: PubMed
    Score: 0.046
  3. The effect of program design on engagement with an internet-based smoking intervention: randomized factorial trial. J Med Internet Res. 2013 Mar 25; 15(3):e69.
    View in: PubMed
    Score: 0.046
  4. Pharmacogenetic smoking cessation intervention in a health care setting: a pilot feasibility study. Nicotine Tob Res. 2013 Feb; 15(2):518-26.
    View in: PubMed
    Score: 0.044
  5. Questions about quitting (Q2): design and methods of a Multiphase Optimization Strategy (MOST) randomized screening experiment for an online, motivational smoking cessation intervention. Contemp Clin Trials. 2012 Sep; 33(5):1094-102.
    View in: PubMed
    Score: 0.044
  6. Understanding oral health promotion needs and opportunities of tobacco quitline callers. Public Health Rep. 2012 Jul-Aug; 127(4):401-6.
    View in: PubMed
    Score: 0.044
  7. Feasibility and acceptability of a multiple risk factor intervention: the Step Up randomized pilot trial. BMC Public Health. 2011 Mar 17; 11:167.
    View in: PubMed
    Score: 0.040
  8. Impact of spirometry feedback and brief motivational counseling on long-term smoking outcomes: a comparison of smokers with and without lung impairment. Patient Educ Couns. 2010 Aug; 80(2):280-3.
    View in: PubMed
    Score: 0.038
  9. Smoking outcome by psychiatric history after behavioral and varenicline treatment. J Subst Abuse Treat. 2010 Jun; 38(4):394-402.
    View in: PubMed
    Score: 0.037
  10. Impact of a brief motivational smoking cessation intervention the Get PHIT randomized controlled trial. Am J Prev Med. 2009 Aug; 37(2):116-23.
    View in: PubMed
    Score: 0.035
  11. Immediate and short-term impact of a brief motivational smoking intervention using a biomedical risk assessment: the Get PHIT trial. Nicotine Tob Res. 2009 Apr; 11(4):394-403.
    View in: PubMed
    Score: 0.035
  12. Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline. J Gen Intern Med. 2009 May; 24(5):563-9.
    View in: PubMed
    Score: 0.035
  13. A comparison of smokers' and nonsmokers' fruit and vegetable intake and relevant psychosocial factors. Behav Med. 2009; 35(1):14-22.
    View in: PubMed
    Score: 0.034
  14. Nicotine patches and uninsured quitline callers. A randomized trial of two versus eight weeks. Am J Prev Med. 2008 Aug; 35(2):103-10.
    View in: PubMed
    Score: 0.033
  15. Predictors of 12-month outcome in smokers who received bupropion sustained-release for smoking cessation. CNS Drugs. 2008; 22(3):239-56.
    View in: PubMed
    Score: 0.032
  16. Interest in an online smoking cessation program and effective recruitment strategies: results from Project Quit. J Med Internet Res. 2006 Aug 22; 8(3):e14.
    View in: PubMed
    Score: 0.029
  17. Proactive, motivationally enhanced smoking cessation counseling among women with elevated cervical cancer risk. Nicotine Tob Res. 2005 Dec; 7(6):881-9.
    View in: PubMed
    Score: 0.028
  18. Patient Experiences With Blood Pressure Measurement Methods for Hypertension Diagnosis: Qualitative Findings From the BP-CHECK Study. Am J Hypertens. 2024 Oct 14; 37(11):868-875.
    View in: PubMed
    Score: 0.026
  19. "I Thought Cancer was a Tobacco Issue": Perspectives of Veterans with and without HIV on Cancer and Other Health Risks Associated with Alcohol and Tobacco/Nicotine Use. AIDS Behav. 2024 Aug; 28(8):2607-2618.
    View in: PubMed
    Score: 0.025
  20. Sitting Time Reduction and Blood Pressure in Older Adults: A Randomized Clinical Trial. JAMA Netw Open. 2024 03 04; 7(3):e243234.
    View in: PubMed
    Score: 0.025
  21. Relationship of Blood Pressure, Health Behaviors, and New Diagnosis and Control of Hypertension in the BP-CHECK Study. Circ Cardiovasc Qual Outcomes. 2024 02; 17(2):e010119.
    View in: PubMed
    Score: 0.024
  22. Is Hypertension Diagnostic Testing and Diagnosis Associated With Psychological Distress? Am J Hypertens. 2024 01 01; 37(1):69-76.
    View in: PubMed
    Score: 0.024
  23. Long-Term Smoking Cessation Outcomes for Sexual Minority Versus Nonminority Smokers in a Large Randomized Controlled Trial of Two Web-Based Interventions. Nicotine Tob Res. 2020 08 24; 22(9):1596-1604.
    View in: PubMed
    Score: 0.019
  24. Comparing Treatment Acceptability and 12-Month Cessation Rates in Response to Web-Based Smoking Interventions Among Smokers Who Do and Do Not Screen Positive for Affective Disorders: Secondary Analysis. J Med Internet Res. 2019 06 19; 21(6):e13500.
    View in: PubMed
    Score: 0.018
  25. Smokers with bipolar disorder, other affective disorders, and no mental health conditions: Comparison of baseline characteristics and success at quitting in a large 12-month behavioral intervention randomized trial. Drug Alcohol Depend. 2018 12 01; 193:35-41.
    View in: PubMed
    Score: 0.017
  26. The effect of socio-demographic factors on mental health and addiction high-cost use: a retrospective, population-based study in Saskatchewan. Can J Public Health. 2018 12; 109(5-6):810-820.
    View in: PubMed
    Score: 0.017
  27. Positive Affect as a Predictor of Smoking Cessation and Relapse: Does It Offer Unique Predictive Value among Depressive Symptom Domains? Subst Use Misuse. 2018 05 12; 53(6):980-988.
    View in: PubMed
    Score: 0.016
  28. Differential prevalence of established risk factors for poor cessation outcomes among smokers by level of social anxiety. Am J Addict. 2017 Mar; 26(2):176-182.
    View in: PubMed
    Score: 0.015
  29. Integrating the patient portal into the health management work ecosystem: user acceptance of a novel prototype. AMIA Annu Symp Proc. 2016; 2016:541-550.
    View in: PubMed
    Score: 0.015
  30. Relationships Between Social Anxiety and Smoking-Specific Experiential Avoidance. J Dual Diagn. 2017 Jan-Mar; 13(1):1-5.
    View in: PubMed
    Score: 0.015
  31. Relationship between cardiovascular risk and lipid testing in one health care system: a retrospective cohort study. BMC Health Serv Res. 2015 Jul 23; 15:281.
    View in: PubMed
    Score: 0.014
  32. Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption. PLoS One. 2015; 10(7):e0126113.
    View in: PubMed
    Score: 0.013
  33. Acceptance and Commitment Therapy and nicotine patch for smokers with bipolar disorder: preliminary evaluation of in-person and telephone-delivered treatment. Bipolar Disord. 2015 Aug; 17(5):560-6.
    View in: PubMed
    Score: 0.013
  34. Engineering for reliability in at-home chronic disease management. AMIA Annu Symp Proc. 2014; 2014:777-86.
    View in: PubMed
    Score: 0.013
  35. Organic cation transporter variation and response to smoking cessation therapies. Nicotine Tob Res. 2014 Dec; 16(12):1638-46.
    View in: PubMed
    Score: 0.013
  36. Positive smoking outcome expectancies mediate the association between negative affect and smoking urge among women during a quit attempt. Exp Clin Psychopharmacol. 2014 Aug; 22(4):332-40.
    View in: PubMed
    Score: 0.012
  37. e-Care for heart wellness: a feasibility trial to decrease blood pressure and cardiovascular risk. Am J Prev Med. 2014 Apr; 46(4):368-77.
    View in: PubMed
    Score: 0.012
  38. Positive smoking outcome expectancies mediate the relation between alcohol consumption and smoking urge among women during a quit attempt. Psychol Addict Behav. 2014 Mar; 28(1):163-72.
    View in: PubMed
    Score: 0.012
  39. Alcohol and associated characteristics among older persons living with human immunodeficiency virus on antiretroviral therapy. Subst Abus. 2014; 35(3):245-53.
    View in: PubMed
    Score: 0.012
  40. Individual and combined effects of multiple high-risk triggers on postcessation smoking urge and lapse. Nicotine Tob Res. 2014 May; 16(5):569-75.
    View in: PubMed
    Score: 0.012
  41. Belief in numbers: When and why women disbelieve tailored breast cancer risk statistics. Patient Educ Couns. 2013 Aug; 92(2):253-9.
    View in: PubMed
    Score: 0.012
  42. Results from a randomized trial of a web-based, tailored decision aid for women at high risk for breast cancer. Patient Educ Couns. 2013 Jun; 91(3):364-71.
    View in: PubMed
    Score: 0.011
  43. Informed choice about breast cancer prevention: randomized controlled trial of an online decision aid intervention. Breast Cancer Res. 2013; 15(5):R74.
    View in: PubMed
    Score: 0.011
  44. Breast cancer anxiety's associations with responses to a chemoprevention decision aid. Soc Sci Med. 2013 Jan; 77:13-9.
    View in: PubMed
    Score: 0.011
  45. Using body mass index data in the electronic health record to calculate cardiovascular risk. Am J Prev Med. 2012 Apr; 42(4):342-7.
    View in: PubMed
    Score: 0.011
  46. The distinct role of comparative risk perceptions in a breast cancer prevention program. Ann Behav Med. 2011 Oct; 42(2):262-8.
    View in: PubMed
    Score: 0.010
  47. Early cessation success or failure among women attempting to quit smoking: trajectories and volatility of urge and negative mood during the first postcessation week. J Abnorm Psychol. 2011 Aug; 120(3):596-606.
    View in: PubMed
    Score: 0.010
  48. A randomized clinical trial of a palmtop computer-delivered treatment for smoking relapse prevention among women. Psychol Addict Behav. 2011 Jun; 25(2):365-71.
    View in: PubMed
    Score: 0.010
  49. Varenicline for smoking cessation: nausea severity and variation in nicotinic receptor genes. Pharmacogenomics J. 2012 Aug; 12(4):349-58.
    View in: PubMed
    Score: 0.010
  50. Women's interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aid. Breast Cancer Res Treat. 2011 Jun; 127(3):681-8.
    View in: PubMed
    Score: 0.010
  51. Adherence to varenicline in the COMPASS smoking cessation intervention trial. Nicotine Tob Res. 2011 May; 13(5):361-8.
    View in: PubMed
    Score: 0.010
  52. Utilization of services in a randomized trial testing phone- and web-based interventions for smoking cessation. Nicotine Tob Res. 2011 May; 13(5):319-27.
    View in: PubMed
    Score: 0.010
  53. Engagement and retention: measuring breadth and depth of participant use of an online intervention. J Med Internet Res. 2010 Nov 18; 12(4):e52.
    View in: PubMed
    Score: 0.010
  54. Resequencing of nicotinic acetylcholine receptor genes and association of common and rare variants with the Fagerström test for nicotine dependence. Neuropsychopharmacology. 2010 Nov; 35(12):2392-402.
    View in: PubMed
    Score: 0.010
  55. Behavioral counseling and varenicline treatment for smoking cessation. Am J Prev Med. 2010 May; 38(5):482-90.
    View in: PubMed
    Score: 0.009
  56. Women's decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid. Breast Cancer Res Treat. 2010 Feb; 119(3):613-20.
    View in: PubMed
    Score: 0.009
  57. A randomized clinical trial evaluating online interventions to improve fruit and vegetable consumption. Am J Public Health. 2010 Feb; 100(2):319-26.
    View in: PubMed
    Score: 0.009
  58. Testing whether decision aids introduce cognitive biases: results of a randomized trial. Patient Educ Couns. 2010 Aug; 80(2):158-63.
    View in: PubMed
    Score: 0.009
  59. Clinical trial participant characteristics and saliva and DNA metrics. BMC Med Res Methodol. 2009 Oct 29; 9:71.
    View in: PubMed
    Score: 0.009
  60. Recruitment to a randomized web-based nutritional intervention trial: characteristics of participants compared to non-participants. J Med Internet Res. 2009 Aug 26; 11(3):e38.
    View in: PubMed
    Score: 0.009
  61. Dopamine genes and nicotine dependence in treatment-seeking and community smokers. Neuropsychopharmacology. 2009 Sep; 34(10):2252-64.
    View in: PubMed
    Score: 0.009
  62. Focus groups inform a web-based program to increase fruit and vegetable intake. Patient Educ Couns. 2009 Nov; 77(2):314-8.
    View in: PubMed
    Score: 0.009
  63. Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting. J Subst Abuse Treat. 2009 Jun; 36(4):428-34.
    View in: PubMed
    Score: 0.008
  64. Communicating side effect risks in a tamoxifen prophylaxis decision aid: the debiasing influence of pictographs. Patient Educ Couns. 2008 Nov; 73(2):209-14.
    View in: PubMed
    Score: 0.008
  65. The impact of a free nicotine patch starter kit on quit rates in a state quit line. Nicotine Tob Res. 2008 Sep; 10(9):1511-6.
    View in: PubMed
    Score: 0.008
  66. Web-based smoking-cessation programs: results of a randomized trial. Am J Prev Med. 2008 May; 34(5):373-81.
    View in: PubMed
    Score: 0.008
  67. Effect of incentives and mailing features on online health program enrollment. Am J Prev Med. 2008 May; 34(5):382-8.
    View in: PubMed
    Score: 0.008
  68. Predictors of outpatient medical appointment attendance among persons with HIV. AIDS Care. 1999 Jun; 11(3):361-73.
    View in: PubMed
    Score: 0.004
  69. Gender differences in response to nicotine replacement therapy: objective and subjective indexes of tobacco withdrawal. Exp Clin Psychopharmacol. 1999 May; 7(2):135-44.
    View in: PubMed
    Score: 0.004

© 2024 Kaiser Permanente